Market Overview

Deutsche Bank Reiterates Buy Rating, $88 PT on Mead Johnson Nutrition

Share:
Related MJN
Earnings Scheduled For January 29, 2015
Morgan Stanley Previews Earnings For 3 Food & Tobacco Stocks
First Mead Johnson Nutrition Company's (MJN) CEO Kasper Jakobsen on Q4 2014 Results - Earnings Call Transcript (Seeking Alpha)

In a report published Wednesday, Deutsche Bank reiterated its Buy rating and $88.00 price target on Mead Johnson Nutrition (NYSE: MJN).

Deutsche Bank noted, “Although the stock has been under pressure given concerns around China growth, we continue to view the LT outlook as compelling. Mead enjoys a modest premium valuation vs. global CPG peers. But we see this as justified given leading global share in a rational category, excellent margins, and investments that should yield high returns.”

Mead Johnson Nutrition closed on Tuesday at $73.59.

Latest Ratings for MJN

DateFirmActionFromTo
Jan 2015Morgan StanleyMaintainsEqual-weight
Jan 2015NomuraInitiates Coverage onBuy
Oct 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MJN)

Around the Web, We're Loving...

Get Benzinga's Newsletters